Rare Diseases Forum 2024: Securing Europe's competitiveness in R&D for people living with rare diseases


Featuring keynotes and panel discussions with a focus on the EU's role in enhancing competitiveness in life sciences, fostering investment in the rare diseases sector, and examining the benefits of a competitive agenda for those with rare diseases. 

The event is convened by Global Counsel on behalf of the forum partners, EURORDIS, RaDiOrg, EFPIA, Eucope, EuropaBio,, UCB, Novo Nordisk, Sanofi & Takeda.